Search research articles
Contact Us
Filters
Showing results (11-20 of 34) with videos related to
Page
of 4
Sort By:
American Journal of Hematology
|
August 28, 2022
A roadmap for clinical trial design in marginal zone lymphoma
Juan Pablo Alderuccio, Thomas Habermann, Russ Kuker, et al.
Blood
|
August 15, 2002
Phase 2 trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with poor-prognosis, intermediate-grade non-Hodgkin lymphoma: an Eastern Cooperative Oncology Group trial (E3493)
Joseph A Sparano, Edie Weller, Tipu Nazeer, et al.
Frontiers in Oncology
|
August 7, 2023
Induction treatment in high-grade B-cell lymphoma with a concurrent <i>MYC</i> and <i>BCL2</i> and/or <i>BCL6</i> rearrangement: a systematic review and meta-analysis
Vanja Zeremski, Siegfried Kropf, Michael Koehler, et al.
American Journal of Hematology
|
October 22, 2021
Hiding in (not so) plain sight: Spontaneous tumor Lysis syndrome due to intravascular large B cell lymphoma
Matthew Ho, Saurabh Zanwar, Patrick Duggan, et al.
Blood Advances
|
July 18, 2024
Transformation of marginal zone lymphoma to Hodgkin lymphoma
Kamilia N Moalem, Juan Pablo Alderuccio, Côme Bommier, et al.
British Journal of Haematology
|
September 12, 2014
Clinical characteristics and healthcare utilization of patients with multicentric Castleman disease
Corey Casper, Dana Y Teltsch, Don Robinson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2003
Randomized, controlled trial of an easy-to-read informed consent statement for clinical trial participation: a study of the Eastern Cooperative Oncology Group
Cathy A Coyne, Ronghui Xu, Peter Raich, et al.
Blood Cancer Journal
|
January 15, 2020
High level MYC amplification in B-cell lymphomas: is it a marker of aggressive disease?
Priyanka A Pophali, Lisa M Marinelli, Rhett P Ketterling, et al.
Leukemia & Lymphoma
|
November 23, 2022
Central nervous system involvement by mantle cell lymphoma
Nicole McLaughlin, Yucai Wang, Thomas Witzig, et al.
The Lancet. Haematology
|
May 30, 2025
Beyond maximum grade: introduction to The Lancet Haematology Adverse Events Reporting Series
Gita Thanarajasingam, Ajay Major, Vishal Bhatnagar, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 34) with videos related to
Sort By:
Page
of 4
American Journal of Hematology
|
August 28, 2022
A roadmap for clinical trial design in marginal zone lymphoma
Juan Pablo Alderuccio, Thomas Habermann, Russ Kuker, et al.
Blood
|
August 15, 2002
Phase 2 trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with poor-prognosis, intermediate-grade non-Hodgkin lymphoma: an Eastern Cooperative Oncology Group trial (E3493)
Joseph A Sparano, Edie Weller, Tipu Nazeer, et al.
Frontiers in Oncology
|
August 7, 2023
Induction treatment in high-grade B-cell lymphoma with a concurrent <i>MYC</i> and <i>BCL2</i> and/or <i>BCL6</i> rearrangement: a systematic review and meta-analysis
Vanja Zeremski, Siegfried Kropf, Michael Koehler, et al.
American Journal of Hematology
|
October 22, 2021
Hiding in (not so) plain sight: Spontaneous tumor Lysis syndrome due to intravascular large B cell lymphoma
Matthew Ho, Saurabh Zanwar, Patrick Duggan, et al.
Blood Advances
|
July 18, 2024
Transformation of marginal zone lymphoma to Hodgkin lymphoma
Kamilia N Moalem, Juan Pablo Alderuccio, Côme Bommier, et al.
British Journal of Haematology
|
September 12, 2014
Clinical characteristics and healthcare utilization of patients with multicentric Castleman disease
Corey Casper, Dana Y Teltsch, Don Robinson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2003
Randomized, controlled trial of an easy-to-read informed consent statement for clinical trial participation: a study of the Eastern Cooperative Oncology Group
Cathy A Coyne, Ronghui Xu, Peter Raich, et al.
Blood Cancer Journal
|
January 15, 2020
High level MYC amplification in B-cell lymphomas: is it a marker of aggressive disease?
Priyanka A Pophali, Lisa M Marinelli, Rhett P Ketterling, et al.
Leukemia & Lymphoma
|
November 23, 2022
Central nervous system involvement by mantle cell lymphoma
Nicole McLaughlin, Yucai Wang, Thomas Witzig, et al.
The Lancet. Haematology
|
May 30, 2025
Beyond maximum grade: introduction to The Lancet Haematology Adverse Events Reporting Series
Gita Thanarajasingam, Ajay Major, Vishal Bhatnagar, et al.
Page
of 4